Anti-WNT8A/ WNT8D functional antibody

Anti-WNT8A/ WNT8D functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to WNT8A/WNT8A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1384-Ab-1/ GM-Tg-hg-SE1384-Ab-2Anti-Human WNT8A monoclonal antibodyHuman
GM-Tg-rg-SE1384-Ab-1/ GM-Tg-rg-SE1384-Ab-2Anti-Rat WNT8A monoclonal antibodyRat
GM-Tg-mg-SE1384-Ab-1/ GM-Tg-mg-SE1384-Ab-2Anti-Mouse WNT8A monoclonal antibodyMouse
GM-Tg-cynog-SE1384-Ab-1/ GM-Tg-cynog-SE1384-Ab-2Anti-Cynomolgus/ Rhesus macaque WNT8A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1384-Ab-1/ GM-Tg-felg-SE1384-Ab-2Anti-Feline WNT8A monoclonal antibodyFeline
GM-Tg-cang-SE1384-Ab-1/ GM-Tg-cang-SE1384-Ab-2Anti-Canine WNT8A monoclonal antibodyCanine
GM-Tg-bovg-SE1384-Ab-1/ GM-Tg-bovg-SE1384-Ab-2Anti-Bovine WNT8A monoclonal antibodyBovine
GM-Tg-equg-SE1384-Ab-1/ GM-Tg-equg-SE1384-Ab-2Anti-Equine WNT8A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1384-Ab-1/ GM-Tg-hg-SE1384-Ab-2; GM-Tg-rg-SE1384-Ab-1/ GM-Tg-rg-SE1384-Ab-2;
GM-Tg-mg-SE1384-Ab-1/ GM-Tg-mg-SE1384-Ab-2; GM-Tg-cynog-SE1384-Ab-1/ GM-Tg-cynog-SE1384-Ab-2;
GM-Tg-felg-SE1384-Ab-1/ GM-Tg-felg-SE1384-Ab-2; GM-Tg-cang-SE1384-Ab-1/ GM-Tg-cang-SE1384-Ab-2;
GM-Tg-bovg-SE1384-Ab-1/ GM-Tg-bovg-SE1384-Ab-2; GM-Tg-equg-SE1384-Ab-1/ GM-Tg-equg-SE1384-Ab-2
Products NameAnti-WNT8A monoclonal antibody
Formatmab
Target NameWNT8A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-WNT8A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1384-Ag-1Recombinant multi-species WNT8A/ WNT8D protein
    CytokineGM-Tg-g-SE1384-Ag-1wingless-type MMTV integration site family, member 8A (WNT8A) protein


    Target information

    Target IDGM-SE1384
    Target NameWNT8A
    Gene ID7478,20890,291678,713764,100855884,101089489,540199,100072609
    Gene Symbol and SynonymsStra11,Wnt-8A,Wnt-8D,WNT8A,WNT8D
    Uniprot AccessionQ9H1J5
    Uniprot Entry NameWNT8A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000061492
    Target ClassificationN/A

    The target: WNT8A, gene name: WNT8A, also named as WNT8D. The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family, and may be implicated in development of early embryos as well as germ cell tumors. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.